Why is Bausch + Lomb Corp. ?
- The company has been able to generate a Return on Capital Employed (avg) of 2.16% signifying low profitability per unit of total capital (equity and debt)
- PRE-TAX PROFIT(Q) At USD -114 MM has Fallen at -86.89%
- DEBT-EQUITY RATIO (HY) Highest at 72.78 %
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.66 times
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -4.90%, its profits have fallen by -13.5%
- Along with generating -4.90% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bausch + Lomb Corp. for you?
High Risk, Medium Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 283.6 MM
Highest at 257
Fallen by -4.64% (YoY
Highest at USD 1,405 MM
Highest at USD 257 MM
Highest at 18.29 %
Highest at USD 63 MM
Highest at 75.19 %
Lowest at 4.53 times
Lowest at USD -281.08 MM
Here's what is working for Bausch + Lomb Corp.
Pre-Tax Profit (USD MM)
Operating Cash Flows (USD MM)
Operating Profit to Interest
Net Sales (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Raw Material Cost as a percentage of Sales
Here's what is not working for Bausch + Lomb Corp.
Net Profit (USD MM)
Debt-Equity Ratio
Net Profit (USD MM)
Debtors Turnover Ratio
Non Operating income






